Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | $3,348.0M | $4,848.0M | $3,840.0M | $3,980.0M | $5,214.0M | $5,506.0M | $5,545.0M | $4,312.0M | $5,577.0M | $5,867.0M | $6,191.0M | $8,470.0M | $9,794.0M | $9,973.0M | $10.3B | $9,674.0M | $5,794.0M | $6,005.0M | $5,335.0M | $7,897.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Amgen Inc.'s last 12-month Operating Income is $6,112.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Amgen Inc.'s Operating Income growth was (32.4%). The average annual Operating Income growth rates for Amgen Inc. have been (11.8%) over the past three years, (9.4%) over the past five years.
Over the last year, Amgen Inc.'s Operating Income growth was (32.4%), which is lower than industry growth of 0.0%. It indicates that Amgen Inc.'s Operating Income growth is Bad.